MPL — Medibank Private Income Statement
0.000.00%
- AU$12.59bn
- AU$12.34bn
- AU$7.80bn
- 73
- 43
- 97
- 80
Annual income statement for Medibank Private, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 6,777 | 7,035 | 7,109 | 7,222 | 7,796 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,323 | 6,399 | 6,551 | 6,784 | 7,084 |
Operating Profit | 454 | 636 | 558 | 438 | 712 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 450 | 632 | 560 | 438 | 712 |
Provision for Income Taxes | |||||
Net Income After Taxes | 316 | 441 | 394 | 309 | 496 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 315 | 441 | 394 | 309 | 493 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 315 | 441 | 394 | 309 | 493 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.118 | 0.18 | 0.201 | 0.038 | 0.152 |
Dividends per Share | |||||
Special Dividends per Share |